Founders Capital Management (Texas)’s T2 Biosystems, Inc TTOO Stock Holding History

Founders Capital Management (Texas)’s Portfolio TTOO Stock Details TTOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2	Closed	-$14	–	434
2023 Q2	$14	Hold	2	–	–	﹤0.01%	395
2023 Q1	$0	Hold	2	–	–	﹤0.01%	411
2022 Q4	$0	Sell	2 -6	-75%	-$1.23K	﹤0.01%	402
2022 Q3	$5K	Hold	8	–	–	﹤0.01%	346
2022 Q2	$6K	Hold	8	–	–	﹤0.01%	362
2022 Q1	$21K	Hold	8	–	–	0.01%	209
2021 Q4	$21K	Buy	8 +2	+33%	+$6.96K	0.01%	209
2021 Q3	$27K	Hold	6	–	–	0.02%	181
2021 Q2	$36K	Buy	6 +2	+50%	+$12.9K	0.02%	145
2021 Q1	$36K	Sell	4 -1	-20%	-$10.6K	0.03%	134
2020 Q4	$32K	Buy	+5	New	+$30.6K	0.02%	144
2020 Q1	$23K	Buy	7 +4	+133%	+$16.6K	0.02%	138
2019 Q4	$18K	Hold	3	–	–	0.01%	192
2019 Q3	$43K	Buy	3 +2	+200%	+$16.1K	0.03%	117
2019 Q2	$10K	Hold	1	–	–	0.01%	260
2019 Q1	$16K	Hold	1	–	–	0.02%	210
2018 Q4	$15K	Hold	1	–	–	0.02%	205
2018 Q3	$22K	Hold	1	–	–	0.02%	173
2018 Q2	$19K	Buy	+1	New	+$38K	0.02%	196
2018 Q1	–	Hold	0	–	–	–	262

Other funds holding TTOO

Banco Santander Madrid, Spain $16.1B AUM 35.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Founders Capital Management (Texas)'s TTOO Position: Q3 2023 in Review

Founders Capital Management (Texas) sold out of T2 Biosystems, Inc (TTOO) in Q3 2023, closing a stake of 2 shares — an estimated $14 sold.

Founders Capital Management (Texas) first reported a position in TTOO in Q2 2018 and held it in 19 quarters. The position peaked at $43K in Q3 2019. 40 funds tracked by Wall St. Rank hold TTOO as of Q3 2023.

Founders Capital Management (Texas) reported no remaining T2 Biosystems, Inc position as of Q3 2023 after selling out during the quarter.
Founders Capital Management (Texas) sold 2 T2 Biosystems, Inc shares in Q3 2023, an estimated $14.
Founders Capital Management (Texas) first reported a position in T2 Biosystems, Inc in Q2 2018 and held it in 19 quarters.
Founders Capital Management (Texas)'s T2 Biosystems, Inc position peaked at $43K in Q3 2019.
40 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q3 2023.

Based on Founders Capital Management (Texas)'s 13F filing for Q3 2023, filed 10 Oct 2023.